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Introduction
Atrial fibrillation (AF) is the most common sustained cardiac 
rhythm disorder.1) Although pharmacological therapy for rate and/or 
rhythm control has been the mainstay of treatment for arrhythmia, 
recently introduced radiofrequency catheter ablation (RFCA) is a 
robust and promising technique for eradicating AF in carefully 
selected patients.2) However, a considerable proportion of patients 
fail to maintain sinus rhythm even after successful RFCA; thus, 
predicting outcome is clinically important for selecting appropriate 
patients before the procedure. 
AF causes various anatomical and electrical changes in the atria, 
which play a pathological role generating and maintaining the 
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Background and Objectives: The prognostic role of the right atrium (RA) compared with that of the left atrium (LA) is unclear in 
patients with atrial fibrillation (AF). We assessed structural changes in both atria and determined their association with recurrence of AF 
after radiofrequency catheter ablation (RFCA).
Subjects and Methods: All 111 patients with nonvalvular AF (87 men; mean age, 57±11 years; 68 with paroxysmal AF) who underwent 
RFCA were enrolled consecutively. Three-dimensional volumes of both atria measured from computed tomography images were compared 
between subjects with and without recurrence of AF during the follow-up. 
Results: Early (<3 months), 6-month, and 1-year recurrence was documented in 26 (24%), 30 (27%), and 36 (32%) patients, respectively. 
Significantly larger RA and LA volume indices  (RAVI and LAVI) were observed in the early, 6-month, and 1-year recurrence groups (p<0.05 
for all). In multivariate analysis, Early recurrence was independently associated with RAVI (for each 10 mL/m2 increase; odds ratio [OR], 
1.31; 95% confidence interval [CI], 1.03–1.66, p= 0.03), but not with LAVI. However, both RAVI and LAVI failed to predict 6-month 
outcomes independently. LAVI was the only independent predictor of 1-year recurrence (for each 10 mL/m2 increase; OR, 1.36; 95% CI, 
1.08–1.71, p=0.009). 
Conclusion: RA enlargement was more closely related to early recurrence of AF after RFCA than LA size. However, LA size, rather than RA 
volume, was a determinant of long-term AF prognosis after RFCA. These findings suggest a temporal pattern in the prognostic implication 
of enlargement in each atrium that switches over time after RFCA for AF. (Korean Circ J 2015;45(4):301-309)
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arrhythmia.3)4) Patients with more severe left atrial (LA) disease 
experience earlier and more frequent AF recurrence after the index 
RFCA. In contrast, because structurally evaluating the chamber is 
difficult with two-dimensional echocardiography, which has been 
the most widely used cardiac imaging modality, knowledge 
regarding the prognostic implications of right atrial (RA) size is 
relatively limited. Multi-detector computed tomography (MDCT) is a 
promising tool for three-dimensional evaluation of cardiac chamber 
anatomy and is superior to conventional echocardiography for that 
purpose. In this study, we investigated the prognostic implications 
of three-dimensional RA and LA enlargement assessed with MDCT 
after RFCA for AF. 
Subjects and Methods
Study population
All 111 patients (87 males; mean age, 57±11 years) with 
nonvalvular AF who underwent RFCA between 2009 and 2011 were 
enrolled consecutively at the Severance Cardiovascular Hospital 
(Seoul, Korea). Patients with any medical history of cardiomyopathy, 
pericardial disease, or valvular heart disease with moderate or 
greater severity or a congenital cardiac abnormality were excluded. 
None of the patients in this cohort suffered from lung diseases, 
including chronic obstructive pulmonary disease or pulmonary 
hypertension which may cause right-heart structural/functional 
changes. Paroxysmal atrial fibrillation (PaAF) was defined as a 
history of one or more episodes of self-terminating AF lasting ≤7 
days. Patients who had an AF episode that lasted >7 days or 
required termination by cardioversion either with antiarrhythmic 
drugs or by direct current cardioversion were allocated into the 
persistent atrial fibrillation (PeAF) group. This study protocol was 
approved by the Institutional Review Board of Severance 
Cardiovascular Hospital, and complied with the Declaration of 
Helsinki (sixth revision). All patients in this study cohort provided 
written informed consent.
Transthoracic echocardiography
Conventional transthoracic echocardiographic evaluations were 
performed using commercially available equipment (Vivid 9, GE 
Vingmed ultrasound, Horten, Norway or Sonos 5500, Philips Medical 
Systems, Andover, MA, USA) in all subjects before the index 
procedure. Standard M-mode, two-dimensional, and color Doppler 
imaging were performed in the parasternal and apical views. Left 
ventricular (LV) ejection fraction was calculated from two-
dimensional recordings using the modified Quinones method. All 
measurements were averaged over five cardiac cycles. The 
echocardiographic data were analyzed by two blinded 
echocardiographer cardiologists.
Multi-detector computed tomography 
Cardiac MDCT scans were performed using a dual-source 
computed tomography (CT) (Somatom Definition Flash, Siemens 
Healthcare, Forchheim, Germany). Scan delay times between the 
start of contrast injection and scanning were determined for each 
patient using the test bolus technique. After a 10 mL intravenous 
injection of iopamidol (Pamiray 370; 370 mg iodine/mL, Dongkook 
Pharma, Seoul, Korea) followed by 20 min of saline at 5 mL/s, 
optimal delay times were determined by automatic evaluation of 
contrast enhancement in the ascending aorta. Contrast-enhanced 
cardiac CT was performed using the triple phase injection method 
Fig. 1. Three-dimensional measurements of right atrial (A), left atrial (B), and left atrial appendage (C) volumes using software (Aquaris Intuition Edition 
V4.4.6, TeraRecon, San Francisco, CA, USA) on multidetector computed tomography images. 
A  B C  
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(60–80 mL iopamidol followed by 30 mL 30% blended iopamidol 
with saline and 20 mL saline at 5 mL/s). Scanning was performed 
using the following parameters: retrospective electrocardiography 
(ECG)-gated spiral acquisitions or prospective axial acquisition 
targeting end-systole, 80–120 kVp and 280–450 mAs depending on 
patient size. Images used to measure maximum atrial volume were 
reconstructed at the end-systolic phase just before atrioventricular 
valve opening at a slice thickness of 0.75 mm, an increment interval 
of 0.5 mm, and a medium-smooth convolution kernel of B36f. All 
atrial volumes were measured by two experienced radiologists with 
consensus, who were unaware of the patients’ clinical and 
electrophysiological data, using software (Aquaris Intuition Edition 
V4.4.6, TeraRecon, San Francisco, CA, USA). Atria were automatically 
or semi-automatically segmented based on the three-dimensional 
threshold method and atrial volumes were determined after 
manually excluding the pulmonary veins and vena cavi (Fig. 1). 
Atrial volume was indexed to each patient’s body surface area 
{right atrial volume indices (RAVI) and left atrial volume indices 
(LAVI), respectively}. Left atrial appendage (LAA) volume was also 
separately measured and indexed to each patient’s body surface 
area.
Radiofrequency catheter ablation procedures 
The electrophysiological study was performed in the post-
absorptive state with the patients sedated with midazolam and 
fentanyl. Three-dimensional geometry of the LA was reconstructed 
with the CARTO (Biosense Webster, Diamond Bar, CA, USA) or NavX 
(St Jude Medical, Inc., Minnetonka, MN, USA) electroanatomic 
mapping system. The circumferential pulmonary vein was isolated 
in all patients using a 3.5-mm irrigated-tip catheter (ThermoCool, 
Biosense Webster, CA, USA). We used a circular mapping catheter 
{Lasso (Biosense Webster, Diamond Bar, CA, USA)} to confirm 
isolation of the pulmonary veins. Successful ablation was defined as 
the elimination of all pulmonary vein potentials along the antrum or 
inside the veins (entry block). If AF was not terminated after 
eliminating all pulmonary vein potentials, linear ablation and 
complex fragmented atrial electrogram ablation were performed. 
Cavotricuspid isthmus ablation was performed in all patients.  
Follow-up
The patients were monitored continuously by ECG during their 
hospital stay before and after the index RFCA. After the index 
procedure, the patients were discharged without routine 
antiarrhythmic drugs and were followed up with a clinical 
examination, ECG, and Holter monitoring at 1, 3, 6, 9, and 12 
months. Patients who developed recurrence of symptoms between 
follow-up visits were evaluated with a clinical examination, ECG, 
and Holter monitoring. AF recurrence within the first 3 months after 
ablation was defined as early recurrence, and anti-arrhythmic drug 
treatment (class Ic or amiodarone) followed by electrical 
cardioversion was initiated. Oral anticoagulation therapy was 
prescribed for at least 3 months. We divided the study subjects 
based on the presence of early recurrence (<3 months), 6-month 
recurrence, or 1-year recurrence of AF after successful catheter 
ablation. 
Statistical analysis
Continuous data are expressed as mean±standard deviation and 
normality tests were performed for each variable. The baseline 
characteristics between the groups were compared using the two-
sample t-test for continuous variables, and the chi-square test and 
Fisher’s exact test for categorical variables. Univariate and multivariate 
logistic regression analyses were performed to identify factors 
associated with early recurrence or long-term outcomes. Pearson’s 
bivariate correlation analysis was used to determine the correlation 
between variables. We calculated the variance inflation factor in the 
multiple regression analysis model to assess multicollinearity. 
Receiver operating characteristics curves were used to determine 
the accuracy of variables for predicting recurrence. A p value <0.05 
was considered significant. 
Results
Baseline characteristics and comparisons between the paroxysmal 
atrial fibrillation and persistent atrial fibrillation groups
The baseline characteristics of the entire cohort are shown in 
Table 1. The clinical characteristics were similar between the PaAF 
and PeAF groups, although more PeAF patients had accompanying 
hypertension (p=0.045) .  The  LV  e ject ion f ract ion on 
echocardiography was not different between the groups; however, 
PeAF patients had a larger LA anterior-posterior diameter (p<0.001). 
PeAF patients had larger RAVI (83±19 vs. 104±29 mL/m2, p<0.001) 
and LAVI (73±18 vs. 101±29 mL/m2, p<0.001) on MDCT evaluation 
than those of PaAF patients. Concurrently, indexed LAA size was 
greater in PeAF (9±3 mL/m2) than that in the PaAF (7±3 mL/m2, 
p<0.001) group. However, RA and LA conduction velocities did not 
differ between the groups. Procedural, fluoroscopic, and ablation 
times were significantly longer in PeAF patients than those in the 
PaAF patients. Additional ablation procedures, including complex 
fractionated atrial electrogram ablation and LA roof or left anterior 
ablation were more frequently performed in the PeAF group. 
Complications after RFCA were noted as one cardiac tamponade 
treated with pericardiocentesis, one stroke, and five puncture site 
hematomas.
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Right atrial volume as a predictor of early recurrence after 
the index radiofrequency catheter ablation
Comparisons of clinical characteristics, echocardiographic 
parameters,  MDCT f indings,  and electrophysiological 
characteristics between patients with early recurrence and 
subjects without early recurrence are shown in Table 2. The 
proportion of PeAF was higher in the early recurrence group than 
that in the no recurrence group (33% vs. 56%, respectively, 
p=0.04), but other demographic findings did not differ between 
the groups. However, both atrial volume indices and indexed LAA 
size measured by MDCT were significantly larger in the early 
recurrence than in the no recurrence group (p<0.05 for all). RAVI 
and LAVI showed no significant multicollinearity when assessed 
by the variance inflation factor tolerance. Early recurrence was 
independently associated with RAVI {for each 10 mL/m2 increase; 
odds ratio (OR), 1.31; 95% confidence interval (CI), 1.03–1.66; 
p=0.03}, but not with LAVI in the multivariate analysis (Table 3). 
RAVI of 89 mL/m2 showed fair sensitivity (0.704) and specificity 
(0.631) for predicting early recurrence (area under curve: 0.691, 
p=0.003).
Predictors of 6-month recurrence after the index 
radiofrequency catheter ablation 
Comparisons of clinical characteristics, echocardiographic 
parameters, MDCT findings, and electrophysiological parameters 
between patients with 6-month recurrence and without recurrence 
Table 1. Baseline clinical characteristics, echocardiographic parameters, and MDCT findings and intergroup comparisons between patients with paroxys-







Male, n (%) 87 (78) 55 (80) 32 (74) 0.51
Age (years) 57±11 56±11 57±12 0.68
CHF, n (%) 4 (4) 2 (3) 2 (5) 0.64
Hypertension, n (%) 43 (38) 21 (30) 22 (51) 0.045*
Age>75 years, n (%) 4 (4) 1 (1) 3 (7) 0.16
Diabetes mellitus, n (%) 5 (5) 2 (3) 3 (7) 0.37
Stroke, n (%) 6 (5) 3 (4) 3 (7) 0.67
Dyslipidemia, n (%) 13 (12)   9 (13) 4 (9) 0.76
CHADS2 score 0.49±0.71 0.41±0.69 0.63±0.73 0.11
Echocardiographic parameters
LVEF (%) 63±7 64±7 63±7 0.60
LA anterior-posterior diameter (mm) 41±6 39±5 45±7 <0.001*
MDCT
RA volume index (mL/m2) 92±27 83±19 104±29 <0.001*
LA volume index (mL/m2) 84±27 73±18 101±29 <0.001*
LAA volume index (mL/m2) 8±3 7±3 9±3 <0.001*
Conduction velocity (cm/sec)
RA 0.66±0.23 0.68±0.24 0.62±0.22 0.29
LA 0.97±0.21 1.00±0.21 0.92±0.21 0.06
Radiofrequency catheter ablation procedure
Procedure time (min) 172±38 160±30 194±38 <0.001*
Fluoroscopic time (min) 46±14 43±14 52±14 <0.001*
Ablation time (sec) 4310±1287 3815±1052 5226±1178 <0.001*
CFAE ablation, n (%) 10 (9) 2 (3)   8 (19) <0.001*
Additional line ablation, n (%) 37 (33)  11 (16) 26 (61) <0.001*
MDCT: multidetector computed tomography, AF: atrial fibrillation, PaAF: paroxysmal atrial fibrillation, PeAF: persistent atrial fibrillation, CHF: congestive 
heart failure, LVEF: left ventricular ejection fraction, LA: left atrium/atrial, RA: right atrium/atrial, LAA: left atrial appendage; CFAE: complex fractionated 
atrial electrogram. *p<0.05  
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Table 2. Comparisons of clinical characteristics, echocardiographic parameters, and MDCT findings of patients according to recurrence after AF catheter 
ablation
 














Male, n (%) 64 (75) 23 (85) 0.43  62 (77) 24 (80) 0.70 58 (77)  28 (78) 0.96
Age (years) 57±11 55±11 0.53 60±11 55±11 0.47 56±10 57±13 0.55
PeAF, n (%) 28 (33) 15 (56) 0.04*  27 (33) 16 (53) 0.06 20 (27)  23 (64) <0.001*
CHF, n (%) 2 (2) 2 (7) 0.25 2 (2) 2 (7) 0.30  2 (3)  2 (6) 0.60
Hypertension, n (%)  31 (37) 12 (44) 0.50 30 (37) 13 (43) 0.55  26 (35)  17 (47) 0.20
Echocardiographic parameters
LV EF (%) 64±7 62±8 0.23 65±7 63±9 0.79 63±7 63±8 0.84
LA diameter (mm) 41±6 43±7 0.16 41±6 43±7 0.10 41±6 44±7 0.008*
MDCT
RA volume index (mL/m2) 86±20 107±33 <0.001* 85±20 105±31 <0.001* 85±21 103±29 0.001*
LA volume index (mL/m2)  81±23 93±35 0.03* 80±23 94±34 0.02* 77±20 98±33 <0.001*
LAA volume index (mL/m2) 7±3  9±4 0.02* 7±3 9±4 0.02* 7±3 8±4 0.06
RA/LA ratio 1.09±0.21 1.20±0.25 0.04* 1.10±0.21 1.17±0.26 0.13 1.13±0.23 1.09±0.23 0.42
Conduction velocity (cm/sec)
RA 0.68±0.24  0.57±0.18 0.08 0.68±0.24 0.61±0.20 0.26 0.67±0.25 0.64±0.21 0.58
LA 0.98±0.22  0.93±0.16 0.39 0.97±0.21 0.97±0.22 0.91 0.97±0.20 0.98±0.23 0.83
MDCT: multidetector computed tomography, AF: atrial fibrillation, PeAF: persistent atrial fibrillation, CHF: congestive heart failure, LVEF: left ventricular 
ejection fraction, LA: left atrium/atrial, RA: right atrium/atrial, LAA: left atrial appendage. *p<0.05
Table 3. Predictors of recurrence over time after successful catheter ablation of atrial fibrillation
Odds ratio 95% confidence interval p
3-month recurrence
Univariate
RA volume index (for each 10 mL/m2 increase) 1.29 1.09-1.53 0.003*
LA volume index (for each 10 mL/m2 increase) 1.18 1.01-1.39 0.04*
LAA volume index (for each 10 mL/m2 increase) 4.64 1.25-17.2 0.02*
Multivariate
RA volume index (for each 10 mL/m2 increase) 1.31 1.03-1.66 0.03*
6-month recurrence
Univariate
RA volume index (for each 10 mL/m2 increase) 1.27 1.08-1.50 0.004*
LA volume index (for each 10 mL/m2 increase) 1.20 1.03-1.42 0.02*
LAA volume index (for each 10 mL/m2 increase) 4.55 1.27-16.3 0.02*
1-year recurrence
Univariate
RA volume index (for each 10 mL/m2 increase) 1.24 1.06-1.45 0.009*
LA volume index (for each 10 mL/m2 increase) 1.39 1.15-1.67 0.001*
Multivariate
LA volume index (for each 10 mL/m2 increase) 1.36 1.08-1.71 0.009*
RA: right atrium/atrial, LA: left atrium/atrial, LAA: left atrial appendage. *p<0.05
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are summarized in Table 2. Demographic findings were grossly 
similar, although the proportion of PeAF tended to be higher in the 
recurrence group with borderline significance (33% vs. 53%, 
respectively, p=0.06). LV ejection fraction and LA anterior-posterior 
diameter did not differ between the groups. However, RAVI and LAVI 
determined by MDCT were significantly greater in patients with 
recurrence than in those without (p<0.05 for all). Both atrial 
volumes failed to independently predict 6-month recurrence in the 
multivariate logistic regression analysis (Table 3). 
Predictors of 1-year recurrence after the index 
radiofrequency catheter ablation 
Comparisons of clinical characteristics, echocardiographic 
parameters, MDCT findings, and electrophysiological parameters 
between patients with long-term recurrence (1-year recurrence) 
and subjects without recurrence are shown in Table 2. The 
proportion of PeAF was significantly higher in patients with 1-year 
recurrence than in those with long-term recurrence (37% vs. 64%, 
respectively, p<0.001), but other demographic findings were similar 
including the CHADS2 score. Echocardiographically measured LA 
anterior-posterior diameter was significantly greater in the 
recurrence group than that in no recurrence group (p=0.008). Both 
atrial volumes determined by MDCT were significantly larger in the 
recurrence group (p<0.05 for all). In a multivariate logistic regression 
analysis, LAVI was the only independent predictor of 1-year 
recurrence (for each 10 mL/m2 increase: OR, 1.36; 95% CI; 1.08–1.71, 
p=0.009). In contrast, RAVI was not an independent determinant of 
1-year recurrence after RFCA for AF (Table 3). LAVI of 86 mL/m2 
showed fair sensitivity (0.639) and specificity (0.733) for predicting 
1-year recurrence (area under curve: 0.710, p<0.001).
Relationship between right atrial volume indices and left 
atrial volume indices
RAVI was positively correlated with LAVI (Fig. 2) (r=0.68, p<0.001). 
The significant linear correlation observed between RAVI and LAVI 
was also observed in the PaAF (r=0.62, p<0.0001) and PeAF groups 
(r=0.61, p<0.001). In addition, we calculated the RA/LA ratio, and the 
values were 1.13±0.25 in the entire study group. Interestingly, the 
RA/LA ratio was significantly higher in the early recurrence group 
than that in subjects without recurrence (Table 2 and Fig. 3). However, 
the RA/LA ratio tended to be not different between patients with and 
without 6-month (data not shown) or 1-year recurrence (Table 2 and 
Fig. 3).  
Discussion
Core findings
We found that: (1) increased RA volume was linearly correlated 
with the severity of LA enlargement in patients with nonvalvular AF; 
(2) RA enlargement was closely associated with early recurrence of 
AF after RFCA than that of LA volume; and (3) LA enlargement, 
rather than RA size, played a key role predicting long-term outcome 
of AF after the index procedure. Our results suggest that RA and LA 
play a potential role in AF recurrence, particularly during the early 
period after RFCA. A temporal pattern was detected in the 
prognostic implications of each atrial volume that changed over 
time after the index procedure. 
Right atrial remodeling in atrial fibrillation and its clinical 
implications 
































◆ Yes without early recurrence
● Yes with early recurrence
A  B  
Fig. 2. Strong linear correlation between the right atrial and left atrial volume indices in patients with/without early recurrence (A) and in patients with/
without 1-year recurrence (B). RAVI: right atrial volume indices, LAVI: left atrial volume indices.
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patients with AF.5-8) Many forms of atriopathies induced by AF play 
a key role in the occurrence and maintenance of the arrhythmia (so 
called “AF begets AF”).4)9)10) However, this knowledge is mainly based 
on LA studies, whereas little is known about the potential 
relationship between RA disease and pathophysiology/prognosis of 
AF. Echocardiography has been traditionally used to structurally 
evaluate the cardiac chambers; however, an evaluation of the RA is 
technically challenging,11) which may, at least in part, be responsible 
for our lack of knowledge regarding the RA not only in patients 
with AF but also in other cardiac diseases. MDCT provides more 
reliable three-dimensionally reconstructed cardiac chamber images 
with higher spatial resolution than that of two-dimensional 
echocardiography; thus, we were able to determine the sizes of 
both atria accurately and relatively free from intra and 
interobserver variations. Anatomical and histological changes in 
the RA in patients with AF have been recognized with recent 
advances in cardiac imaging tools and electrophysiology.12-14) In 
an insightful study conducted in patients with AF who 
underwent RFCA, O’Neill et al.15)M. reported that about 1 in 5 AF 
events have a RA origin. In the current study, we observed that 
RA size increased in a close association with LA enlargement in 
patients with AF. In addition, patients with a more chronic form of 
AF suffer more severe RA structural changes. 
Right atrium predicts early recurrence after the index 
radiofrequency catheter ablation 
Early recurrence following RFCA of AF is relatively common, and 
the rate of early recurrence is 37.8% (range 15.9–65.0%) in multiple 
investigations implementing a 3-month blanking period.16) Although 
the exact mechanisms for early recurrence after RFCA remain to be 
determined, numerous predictors have been suggested,17) such as 
acute inflammation, local irritation, and/or increased levels of 
circulating catecholamines after RFCA.18) We reported previously 
that RA size is an independent predictor of early recurrence, 
whereas LA volume is not.19) In the current study, we further support 
our previous observations in a larger cohort. The data from the 
current study suggest that chronic RA disease also affects early 
outcomes after RFCA, and that it may be more important than LA 
size in terms of predicting early recurrence. 
LA enlargement has been reportedly correlated with early 
recurrence;18)20-23) however, those investigators did not include RA 
volume in their data analysis. In the current study, patients with 
severe LA enlargement were clinically excluded before the procedure 
by the attending cardiologists. Therefore, our data can be interpreted 
as: (1) a current RFCA technique can sufficiently eradicate the 
pathological substrate for AF in LA; thus, (2) RA volume has an 
independent and additional prognostic implication, which is greater 
p<0.001
p=0.001
         No           Yes
         No            Yes
          No            Yes
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Fig. 3. Comparisons of both atrial volume indices and the ratio of right atrial (RA) volume to left atrial (LA) size between patients with/without early (A) 
or 1-year recurrence (B). Note that RA/LA is significantly higher in the early recurrence group, but not in the 1-year recurrence group. RAVI: right atrial 
volume indices, LAVI: left atrial volume indices.  
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than LA size, for early recurrence in carefully selected patients for 
RFCA who have a “not-so-large” LA. In contrast, we failed to 
determine the prognostic implications of RA or LA conduction 
velocity. 
Determinants of longer-term outcomes after radiofrequency 
catheter ablation of atrial fibrillation
We observed a temporal change in the prognostic implication 
pattern of each atrial size after RFCA (i.e., RAVI for early recurrence 
and LAVI for 1-year recurrence). RA size remained greater in patients 
with longer-term recurrence (6-month and 1-year recurrence), but 
it failed to independently predict longer-term recurrence. We also 
observed that LA volume served as a key predictor of post RFCA 
longer-term recurrence, which is parallel with data from other 
investigations.20)23-27) The unique findings of our study are that 
enlargement of the LA predicts AF recurrence independently from 
RA size, and that RA structural changes have a limited role in terms 
of predicting long-term maintenance of sinus rhythm after the 
index procedure. This result is contradictory with the findings of 
Akutsu et al.28) who emphasized the role of RA as a long-term 
prognosticator after RFCA in PaAF patients. The discrepancy might 
be explained by the different study groups (inclusion of PeAF or not) 
because our results demonstrate that the proportion of PeAF 
patients in the 1-year recurrence group was greater than that in the 
early recurrence group, and that RA volume was not as strong as LA 
size for predicting 1-year recurrence. Therefore, a diseased LA serves 
as a more important nidus for the arrhythmia substrate than RA, as 
AF becomes more chronic. 
Limitations 
Our study is based on data from a single tertiary center; thus, the 
study group was not representative of all patients with AF. However, 
this is the largest study investigating RA using MDCT in patients 
with AF. Second, although MDCT is a promising diagnostic modality 
for measuring of cardiac chamber size, the method has not been 
widely validated. Finally, RFCA for AF decreases LA size27); thus, the 
change in RA size after the index procedure is essential to elucidate 
reverse RA remodeling. Unfortunately, we did not perform a follow-
up RA size measurement in our cohort. 
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